743
Views
43
CrossRef citations to date
0
Altmetric
FORENSIC APPLICATIONS

Distinguishing between Neuropsychological Malingering and Exaggerated Psychiatric Symptoms in a Neuropsychological Setting

, , , , &
Pages 547-564 | Accepted 12 Mar 2007, Published online: 24 Jun 2010
 

Abstract

It is unclear whether symptom validity test (SVT) failure in neuropsychological and psychiatric domains overlaps. Records of 105 patients referred for neuropsychological evaluation, who completed the Test of Memory Malingering (TOMM), Reliable Digit Span (RDS), and Millon Clinical Multiaxial Inventory–III (MCMI–III), were examined. TOMM and RDS scores were uncorrelated with MCMI–III symptom validity indices and factor analysis revealed two distinct factors for neuropsychological and psychiatric SVTs. Only 3.5% of the sample failed SVTs in both domains, 22.6% solely failed the neuropsychological SVT, and 6.1% solely failed the psychiatric SVT. The results support a dissociation between neuropsychological malingering and exaggeration of psychiatric symptoms in a neuropsychological setting.

ACKNOWLEDGMENTS

The authors acknowledge Danielle Raines for her assistance with data entry. The first author acknowledges fellowship support from the Drexel University College of Arts & Sciences and Natural Sciences & Engineering Research Council of Canada.

Notes

a TOMM = Test of Memory Malingering.

b n = 32.

c MCMI = Millon Clinical Multiaxial Inventory–Base Rate scores.

a TOMM = Test of Memory Malingering.

b n = 77.

c MCMI = Millon Clinical Multiaxial Inventory–Base Rate scores.

a RDS = Reliable Digit Span (n = 77).

*Two-tailed p < .01.

The intercorrelation of the factors was r = –.13 (p = .25).

Overlap of participants passing or failing the TOMM and exaggerating or not exaggerating psychiatric symptoms on the MCMI–III (Scale Z cutoff BR ≥ 85).

TOMM + = valid TOMM; TOMM– = failed TOMM; MCMI + = Scale Z BR < 85; MCMI − = Scale Z BR ≥ 85.

TOMM + = valid TOMM; TOMM − = failed TOMM; MCMI + = Scale Z BR < 85; MCMI − = Scale Z BR ≥ 85.

*Significantly different from one another (p < .01).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.